Evaluation of Drug Utilization Patterns and Prescription Trends in Patients with Hypothyroidism and Hyperthyroidism in a Tertiary Care Hospital

Year : 2026 | Volume : 16 | Issue : 02 | Page : 1 5
    By

    Mohd. Farhan,

  • Nalini Kanta Sahoo,

  • Alex Martin,

  • Rajesh Nath,

  • Asad Jamal Ansari,

  • Ebadurrahman,

  • Saurabh Kumar Chauhan,

  1. Researcher, Faculty of Pharmaceutical Sciences, Rama University, Kanpur, Uttar Pradesh, India
  2. Researcherq, Faculty of Pharmaceutical Sciences, Rama University, Kanpur, Uttar Pradesh, India
  3. Researcher, Faculty of Pharmaceutical Sciences, Rama University, Kanpur, Uttar Pradesh, India
  4. Researcher, Faculty of Pharmaceutical Sciences, Rama University, Kanpur, Uttar Pradesh, India
  5. Researcher, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India
  6. Researcher, Department of Pharmacology, College of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India
  7. Researcher, Department of Pharmacology, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, India

Abstract

Background: Endocrine disorders affecting the thyroid gland represent some of the most frequently encountered conditions globally, necessitating prolonged therapeutic intervention and vigilant clinical surveillance. The evaluation of Drug utilization patterns (DUE) serves an essential function in examining prescriptive behaviours and promoting appropriate pharmaceutical management. Objective: To evaluate drug utilization patterns, prescribing trends, and rationality of therapy in patients with hypothyroidism and hyperthyroidism. Methods: A prospective, cross-sectional observational investigation was performed across six months within the ambulatory care division of a tertiary healthcare facility. The study encompassed 200 patients with confirmed thyroid pathology. Data were collected from prescriptions and patient interviews and analysed using WHO prescribing indicators. Results: Among 200 patients, hypothyroidism was more prevalent (70%) than hyperthyroidism (30%), with a higher proportion of females (70%). Levothyroxine was the most commonly prescribed drug in hypothyroid patients, while carbimazole was predominantly used in hyperthyroidism. Co-prescription of calcium and iron supplements was frequent. Mild polypharmacy (25%) and drug–drug interactions, particularly involving levothyroxine, were observed. Prescribing practices were largely consistent with clinical guidelines. Conclusion: The study demonstrates largely rational prescribing patterns in thyroid disorder management. However, improved monitoring and awareness of drug interactions are essential to optimize therapeutic outcomes.

Keywords: Drug utilization, hypothyroidism, hyperthyroidism, levothyroxine, carbimazole, who prescribing indicators

[This article belongs to Research and Reviews: A Journal of Medicine ]

How to cite this article:
Mohd. Farhan, Nalini Kanta Sahoo, Alex Martin, Rajesh Nath, Asad Jamal Ansari, Ebadurrahman, Saurabh Kumar Chauhan. Evaluation of Drug Utilization Patterns and Prescription Trends in Patients with Hypothyroidism and Hyperthyroidism in a Tertiary Care Hospital. Research and Reviews: A Journal of Medicine. 2026; 16(02):1-5.
How to cite this URL:
Mohd. Farhan, Nalini Kanta Sahoo, Alex Martin, Rajesh Nath, Asad Jamal Ansari, Ebadurrahman, Saurabh Kumar Chauhan. Evaluation of Drug Utilization Patterns and Prescription Trends in Patients with Hypothyroidism and Hyperthyroidism in a Tertiary Care Hospital. Research and Reviews: A Journal of Medicine. 2026; 16(02):1-5. Available from: https://journals.stmjournals.com/rrjom/article=2026/view=249698


References

  1. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018 May;14(5):301–16.
  2. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep 23;390(10101):
    1550–62.
  3. Song F, Bao C, Deng M, Xu H, Fan M, Paillard-Borg S, et al. The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus. Endocrine. 2017 Jan;
    55(1):179–85.
  4. Khatiwada S, Kc R, Gautam S, Lamsal M, Baral N. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr Disord. 2015 Oct 29;15(1):65.
  5. Liu H, Peng D. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. Endocr Connect. 2022 Feb 1;11(2). doi: 1530/EC-21-0002.
  6. Gluvic ZM, Zafirovic SS, Obradovic MM, Sudar-Milovanovic EM, Rizzo M, Isenovic ER. Hypothyroidism and risk of cardiovascular disease. Curr Pharm Des. 2022 Jul 1;28(25):2065–72.
  7. Vizdiklar C, Aydin V, Gultekin O, Tazegul G, Akici A. Changes in nationwide thyroid hormone replacement use during the pandemic: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) Study. Naunyn Schmiedebergs Arch Pharmacol. 2025 Dec;398(12):17201–9.
  8. Valladales-Restrepo LF, Londoño-Cano DA, Muñoz-Velez CM, Soto-Romero LM, Tafur-Ramirez ME, Rojas-Varón MJ, et al. Patterns and persistence of use, effectiveness, safety, clinical inertia, and adherence related to Levothyroxine treatment with real-world evidence. An observational, longitudinal and retrospective study. Endocrine. 2026 Feb 16;91(1):84.
  9. Oteri V, Volpe S, Lopes M, Sceusa G, Tumminia A, Belfiore A, et al. Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review. Endocrine. 2025 Jan;87(1):48–58.
  10. Nishat S, Mueka IN, Hassan MU, Pandey RK, Lwin BB, Vashishta A, et al. Effect of levothyroxine therapy on the lipid profile of patients with hypothyroidism: a systematic review. Cureus. 2024 Jul 23;16(7).
  11. Singh R, Tandon A. Levothyroxine Administration Techniques Audit and Utility of its Assessment at Each Visit: A Hospital-based Mixed Model Study. Indian J Endocrinol Metab. 2025 Sep 1;29(5):567–72.
  12. Meneses JK, Muniz DA, Moroto D, Martins JR, Janovsky CC. The Influence of Health Literacy on the Control of Hypothyroidism in Patients Under Levothyroxine Treatment. Clin Endocrinol. 2026 Feb;104(2):167–74.
Regular Issue Subscription Original Research
Volume 16
Issue 02
Received 09/04/2026
Accepted 14/04/2026
Published 15/07/2026
Publication Time 97 Days
49

Login


My IP

PlumX Metrics